Regulatory Q&A Forum

Ask questions, share knowledge, and get help from the regulatory community

When preparing a premarket submission for a connected medical device, such as a wearable heart monitor or an integrated continuous glucose monitoring system (iCGM), how should a sponsor structure the ...

💬 1 👁️ 18 👍 0
Asked: 1 months ago
Asked by Lo H. Khamis

When developing a novel Class II diagnostic device that falls under an existing classification regulation, such as a test system under 21 CFR Part 862, how can a sponsor strategically determine the ap...

💬 1 👁️ 17 👍 0
Asked: 1 months ago
Asked by Lo H. Khamis

As the medical device industry prepares for mandatory eSTAR use and potential updates to key standards like the ISO 10993 series, how should sponsors strategically plan and document their biocompatibi...

💬 1 👁️ 18 👍 0
Asked: 1 months ago
Asked by Lo H. Khamis

With the European Chemicals Agency (ECHA) increasing its focus on enforcement, particularly with projects signaling more rigorous inspections of Only Representatives (ORs) expected in 2026, how should...

💬 1 👁️ 18 👍 0
Asked: 1 months ago
Asked by Lo H. Khamis

When preparing a premarket submission for a connected Class II medical device, such as an integrated continuous glucose monitoring system (iCGM) identified under 21 CFR 862.1355, how can sponsors effe...

💬 1 👁️ 26 👍 1
Asked: 1 months ago
Asked by Lo H. Khamis

With international standards for biological evaluation undergoing periodic revisions and regulatory bodies continually updating their lists of recognized consensus standards, how should medical device...

💬 1 👁️ 22 👍 1
Asked: 1 months ago
Asked by Lo H. Khamis

For non-UK manufacturers aiming to place medical devices on the market in Great Britain (England, Wales, and Scotland), appointing a UK Responsible Person (UKRP) is a mandatory requirement. As the UK’...

💬 1 👁️ 23 👍 0
Asked: 1 months ago
Asked by Lo H. Khamis

When preparing a premarket submission for a complex, network-connected in vitro diagnostic (IVD), such as a drug metabolizing enzyme genotyping system classified under 21 CFR 862.3360, how can a spons...

💬 1 ✓ 👁️ 15 👍 0
Asked: 1 months ago
Asked by Lo H. Khamis

Considering the significant evolution of UK environmental regulations, particularly the upcoming change from August 2025 that designates Online Marketplaces (OMPs) as a new producer class, what is a r...

💬 1 👁️ 16 👍 2
Asked: 1 months ago
Asked by Lo H. Khamis

Given the anticipated 2026 updates to global biocompatibility standards and the potential for regulatory divergence if FDA does not fully adopt new international norms, how should medical device manuf...

💬 1 👁️ 30 👍 1
Asked: 1 months ago
Asked by Lo H. Khamis

As the transition period for Great Britain's medical device regulations continues, non-UK manufacturers must prepare for significant updates to the role of the UK Responsible Person (UKRP). With gover...

💬 1 👁️ 16 👍 2
Asked: 1 months ago
Asked by Lo H. Khamis

For non-EU cosmetic brands aiming to enter or remain on the European market, appointing an EU-based Responsible Person (RP) is a fundamental legal requirement. While the direct costs of RP services ar...

💬 1 ✓ 👁️ 22 👍 0
Asked: 1 months ago
Asked by Lo H. Khamis

Given recent UK regulatory changes that classify Online Marketplaces (OMPs) as producers, what are the comprehensive requirements for appointing and managing a representative for WEEE (Waste Electrica...

💬 1 👁️ 32 👍 1
Asked: 1 months ago
Asked by Lo H. Khamis

When developing a biocompatibility strategy for a novel medical device—such as an implantable sensor with both metal and polymer components—how can sponsors move beyond a simple testing checklist to c...

💬 1 👁️ 29 👍 2
Asked: 1 months ago
Asked by Lo H. Khamis

For medical device manufacturers based outside the United Kingdom, appointing a UK Responsible Person (UKRP) is a mandatory step for placing devices on the market in Great Britain. With the UK's regul...

💬 1 👁️ 22 👍 0
Asked: 1 months ago
Asked by Lo H. Khamis

As the EU regulatory landscape for cosmetics evolves, particularly with significant safety and substance requirements anticipated around 2026, selecting an EU Responsible Person (RP) is a critical com...

💬 1 👁️ 23 👍 0
Asked: 1 months ago
Asked by Lo H. Khamis

For a medical device or SaMD manufacturer processing the data of EU residents, appointing a GDPR Article 27 Representative is a key compliance step. When budgeting for future operational costs, such a...

💬 1 👁️ 20 👍 0
Asked: 1 months ago
Asked by Lo H. Khamis

As medical device manufacturers plan for global market access, how can they develop a unified biocompatibility strategy that satisfies both the US FDA's expectations and the EU MDR's requirements, par...

💬 1 ✓ 👁️ 21 👍 1
Asked: 1 months ago
Asked by Lo H. Khamis

As the UK regulatory landscape for medical devices continues to evolve, non-UK manufacturers must establish a relationship with a UK Responsible Person (UKRP) to place devices on the Great Britain mar...

💬 1 👁️ 13 👍 0
Asked: 1 months ago
Asked by Lo H. Khamis
Showing page 10 of 54 (1079 total questions)